KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Ginkgo Bioworks Holdings (DNA) Total Current Liabilities (2020 - 2025)

Historic Total Current Liabilities for Ginkgo Bioworks Holdings (DNA) over the last 6 years, with Q3 2025 value amounting to $115.3 million.

  • Ginkgo Bioworks Holdings' Total Current Liabilities rose 74.63% to $115.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was $115.3 million, marking a year-over-year increase of 74.63%. This contributed to the annual value of $107.3 million for FY2024, which is 3453.8% down from last year.
  • Per Ginkgo Bioworks Holdings' latest filing, its Total Current Liabilities stood at $115.3 million for Q3 2025, which was up 74.63% from $96.7 million recorded in Q2 2025.
  • In the past 5 years, Ginkgo Bioworks Holdings' Total Current Liabilities ranged from a high of $191.7 million in Q1 2023 and a low of $1.4 million during Q1 2021
  • Over the past 5 years, Ginkgo Bioworks Holdings' median Total Current Liabilities value was $134.8 million (recorded in 2021), while the average stood at $126.1 million.
  • As far as peak fluctuations go, Ginkgo Bioworks Holdings' Total Current Liabilities skyrocketed by 1110024.59% in 2022, and later plummeted by 4178.89% in 2025.
  • Ginkgo Bioworks Holdings' Total Current Liabilities (Quarter) stood at $134.8 million in 2021, then grew by 28.35% to $173.0 million in 2022, then decreased by 5.26% to $163.9 million in 2023, then crashed by 34.54% to $107.3 million in 2024, then grew by 7.47% to $115.3 million in 2025.
  • Its last three reported values are $115.3 million in Q3 2025, $96.7 million for Q2 2025, and $115.7 million during Q1 2025.